Netflix’s advertising platform plans include The Trade Desk
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Headphones blast Sonos into inner space
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s game-changing lung cancer treatment gains FDA approval
Thousand Oaks-based Amgen has received approval from the U.S. Food and Drug Administration for its treatment, Imdelltra, which is used on adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. Announced May 16, Amgen said in a press release that Imdelltra has received accelerated approval based on “encouraging Read More →
Arcutis treatment helps deliver Q1 earnings beat
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Building something special: Santa Barbara software startup focuses on public works
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
HTSI aims to bring robust superconductor industry to Santa Barbara
Ray Karam is no stranger to the startup world, but his latest company — High Temperature Superconductors — is more than a startup, it is a true passion project that is beginning to make a big impact from its Santa Barbara headquarters. “It’s not as though I had to start another company. Financially, I could have retired,” Read More →
Amgen shares pop 12% after excitement from obesity drug candidate
Shares of Thousand Oaks-based Amgen gained 12% on May 3, one day after the company disclosed its earnings for the first quarter of 2024 and highlighted the excitement around its weight-loss drug. During the company’s earnings call, Amgen CEO Bob Bradway commented on their obesity drug candidate, MariTide. He noted that while the company does Read More →
